 CANbridge Pharma completed a 43 million Series E financing that is a follow-on to its 98 million Series D round, announced in February. Pfizer and Germanys BioNTech announced their partnered mRNA COVID-19 vaccine has been approved for use in the UK, the first acceptance of a coronavirus vaccine in the west. 